|
Mechanism5-HT2A receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date13 Aug 2009 |
100 Clinical Results associated with Li An (Hong Kong) Co., Ltd.
0 Patents (Medical) associated with Li An (Hong Kong) Co., Ltd.
100 Deals associated with Li An (Hong Kong) Co., Ltd.
100 Translational Medicine associated with Li An (Hong Kong) Co., Ltd.